In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET. Mecca AP, Chen MK, O'Dell RS, Naganawa M, et al. Alzheimers Dement 2020 May 13. doi: 10.1002/alz.12097.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mecca AP, Chen MK, O'Dell RS, Naganawa M, et al. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET. Alzheimers Dement 2020 May 13. doi: 10.1002/alz.12097.
PMID: 32400950